Analyst Ratings for Genomic Health Inc. (GHDX)

Updated: 2017-07-28

Genomic Health Inc. (NASDAQ:GHDX) was awarded an average rating of Hold from investment analysts following the stock. A consensus rating of Hold was previously issued for GHDX last month.

3 analysts declared GHDX a buy, 0 issued an overweight rating, 8 issued a hold rating, 1 gave an underweight rating, and 1 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has decreased by 1. During this time, the number of analysts bearish on the stock has increased by 0.

Investment analysts gave a few price targets for GHDX. The highest price target was 40, implying a possible profit of 23.65 percent. The most pessimistic analyst gave a price target of 27, implying potential capital losses of -16.54 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0 percent. The average change in earnings estimates over the last 90 days is -200 percent. Meanwhile, fiscal year estimates have been revised upwards by 0 percent, compared to last month. If we look at the last 90 days instead, we find a net average change of -25 percent in FY estimates.

Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, while 0 analysts revised their estimates downwards. Also over the last month, 0 analysts increased their estimates for the FY earnings, compared to 0 analysts that revised their FY estimates downwards.

In the trailing 52-weeks, GHDX hit 33.97 at the highest peak, while it's lowest trading point was 25.66. Today's price is 26.07 percent above the 52-week low, and below the high by 4.77 percent. GHDX has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The GHDX value stock report compares GHDX to some of its peers using value stock charts. The stock has a market capitalization of $1.1 billion. GHDX's next earnings release will be on 0000-00-00, which is days away.